Financhill
Back

ACADIA Pharmaceuticals Vs. Viking Therapeutics Industry Stock Comparison

Sell
31

ACAD
ACADIA Pharmaceuticals

Last Price:
15.08
Seasonality Move:
7.19%
Buy
56

VKTX
Viking Therapeutics

Last Price:
67.50
Seasonality Move:
5.84%
Sell
31
ACADIA Pharmaceuticals (ACAD) is a Sell

Is ACADIA Pharmaceuticals a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals [ACAD] share price is $15.10. The Score for ACAD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $67.52. The Score for VKTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals's stock price today?

  • The ACADIA Pharmaceuticals share price today is $15.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $67.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 32.73 Sell
Chaikin Money Flow: 1207626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.42 - 17.24) Sell
Bollinger Bands (100): (16.99 - 27.21) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 42.77 Sell
Chaikin Money Flow: 326510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.42 - 77.72) Sell
Bollinger Bands (100): (28.89 - 78.83) Buy

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.05 Buy
20-day SMA: 16.15 Sell
50-day SMA: 17.4 Sell
200-day SMA: 23.39 Sell
8-day EMA: 15.27 Sell
20-day EMA: 16.02 Sell
50-day EMA: 17.88 Sell
200-day EMA: 21.75 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.54 Sell
20-day SMA: 73.77 Sell
50-day SMA: 71.98 Sell
200-day SMA: 33.54 Buy
8-day EMA: 71.5 Sell
20-day EMA: 72.74 Sell
50-day EMA: 68.56 Sell
200-day EMA: 42.58 Buy

ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.53 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

ACADIA Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):